Supplement Services, LLC – Trademark Portfolio
Entity Type: 16
Supplement Services, LLC holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include ARIMATEST, DECADRIVE, MUSCLEMEDS, XERO LIMITS, and AMINO DECANATE. The owner is based in Cedar Grove, NJ.
10 Canfield Drive
Cedar Grove, NJ 07009
Showing of trademarks Trademarks
Trademark Classifications
Supplement Services, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does Supplement Services, LLC have?
Supplement Services, LLC has 16 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 abandoned, 7 cancelled.
What trademark classes does Supplement Services, LLC file in?
Supplement Services, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Supplement Services, LLC's most well-known trademarks?
Supplement Services, LLC's registered trademark portfolio includes well-known marks such as ARIMATEST, DECADRIVE, MUSCLEMEDS, XERO LIMITS, and AMINO DECANATE. These are among 5 currently registered trademarks in the portfolio.
What is Supplement Services, LLC's trademark registration success rate?
Supplement Services, LLC has a 31% trademark registration rate, with 5 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.